Overuse of proton pump inhibitors

Keyphrases

• Proton Pump Inhibitors 100%
• Endoscopy 27%
• Gastric Cancer 18%
• Esophagitis 18%
• H2-receptor Antagonists 18%
• Australia 9%
• Tasmania 9%
• Economic Concern 9%
• Number of Patients 9%
• Medical Records 9%
• Demographic Variables 9%
• Hospitalization 9%
• Teaching Hospital 9%
• Smokers 9%
• Patient Symptoms 9%
• Potential Adverse Effects 9%
• Retrospective Review 9%
• Safety Concerns 9%
• Prolonged Exposure 9%
• Acute Gastrointestinal Bleeding 9%
• Gastric Carcinoid 9%
• Proton Pump Inhibitor Therapy 9%
• Recurrent Ulceration 9%
• Gastroesophageal Reflux 9%
• Approved Indication 9%
• Gastroesophageal Reflux Disease 9%
• Pharmaceutical Benefits 9%
• Clinical Variables 9%

Medicine and Dentistry

• Proton-Pump Inhibitor 100%
• Endoscopy 25%
• Abdominal Cancer 16%
• Esophagitis 16%
• H2 Antagonist 16%
• Adverse Effect 8%
• Medical Record 8%
• Long Term Exposure 8%
• Agent Study 8%
• Gastrointestinal Bleeding 8%
• Gastroesophageal Reflux 8%
• Jejunum Ulcer 8%
• Esophageal Disease 8%
• Carcinoid 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Proton Pump Inhibitor 100%
• Esophagitis 16%
• Abdominal Cancer 16%
• Histamine H2 Receptor Antagonist 16%
• Long Term Exposure 8%
• Gastrointestinal Hemorrhage 8%
• Carcinoid 8%
• Gastroesophageal Reflux 8%
• Esophagus Disease 8%
• Peptic Ulcer 8%
• Jejunum Ulcer 8%